Life Biosciences Co., Ltd. (LifeBio) was established in 2021 with a mission to create a world-class platform for providing experimental animals and innovative drug and device R&D services, empowering advancements in life sciences and biomedical research.
The company specializes in key areas such as central nervous system and brain sciences, psychiatric and neurological modulation, chronic metabolic diseases, oncology, ophthalmology, and more. LifeBio provides nearly 200 specialized disease models and experimental services, including spontaneous disease models, induced models, gene-edited models, and surgical models. The company places a strong emphasis on the strategic value of mid- and large-sized animal models in accelerating clinical translation and validation of groundbreaking drugs and innovative devices. The teams at LifeBio have delivered first-class services to nearly all major pharmaceutical companies worldwide.
